VOLUME 140: ATRAZINE, ALACHLOR, AND VINCLOZOLIN
Lyon, France
28 October to 4 November 2025
CALL FOR EXPERTS
Closing date: 16 December 2024
IARC is seeking scientists who wish to be considered for membership in the Working Group that will develop monographs on the agents that will be reviewed in this volume. Working Group Members will ascertain that all appropriate studies in their area of expertise have been identified; prepare, review, and revise preliminary working papers that critically review the pertinent scientific literature; and participate in a meeting to discuss and revise the pre-meeting texts, and to reach consensus evaluations of the strength of evidence of carcinogenicity.
Eligible scientists generally have published significant research related to the exposure or carcinogenicity of the agents that will be reviewed, and IARC uses literature searches to identify most experts. Consequently, IARC is especially interested in finding scientists whose relevant publications may not be found through standard literature searches. Nomination of women and of candidates from low- and middle-income countries is particularly encouraged.
Self-nominations are encouraged. Each nomination should include:
-
- Curriculum vitae of the proposed candidate.
- Separate list of the candidate’s publications that are relevant to the carcinogenicity of the agents that will be reviewed. For each study or analysis published during the past 5 years, identify the sponsors of the work presented in the paper. For review articles and commentaries, identify the sponsors of the paper.
- WHO Declaration of Interests to disclose associations with parties that have an interest in any agent that will be reviewed.
- Code of Conduct for IARC/WHO Experts.
Please send your nominations before the closing date by email (imo-secretary@iarc.who.int).
Public nominations will be combined with those identified by IARC and other national and international health agencies. IARC will select an interdisciplinary Working Group based on (a) knowledge and experience and (b) absence of real or apparent conflicts of interests. Consideration will also be given to demographic diversity and balance of scientific findings and views.
To assure public confidence that the Working Group is free from links to interested parties and that special interests cannot influence the meeting, experts with a real or apparent conflict of interests may participate only in a limited capacity. They will not serve as meeting chair or subgroup chair, draft text that pertains to the description or interpretation of cancer data, or participate in the evaluations. Such experts will be invited only when necessary (someone who has published significant relevant research and comparable knowledge cannot be found among those without conflicts), and the conflicting interests will be disclosed.
Within 1 month of the closing date, IARC will send preliminary invitations to the experts selected. Their names and principal affiliations will be available on this website.
Thank you for your interest in the IARC Monographs.
Roland Wedekind, Responsible Officer for Volume 140
Mary Schubauer-Berigan, Head of the IARC Monographs programme
Posted 23 September 2024